AU6097896A - Oral delivery of gene constructs - Google Patents

Oral delivery of gene constructs

Info

Publication number
AU6097896A
AU6097896A AU60978/96A AU6097896A AU6097896A AU 6097896 A AU6097896 A AU 6097896A AU 60978/96 A AU60978/96 A AU 60978/96A AU 6097896 A AU6097896 A AU 6097896A AU 6097896 A AU6097896 A AU 6097896A
Authority
AU
Australia
Prior art keywords
oral delivery
gene constructs
constructs
gene
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60978/96A
Other languages
English (en)
Inventor
Peter E Daddona
Gamil G. De Chadarevian
Joseph A. Fix
Phyllis I. Gardner
Howard B. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AU6097896A publication Critical patent/AU6097896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU60978/96A 1995-06-07 1996-06-07 Oral delivery of gene constructs Abandoned AU6097896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47596195A 1995-06-07 1995-06-07
US475961 1995-06-07
PCT/US1996/009371 WO1996040081A2 (fr) 1995-06-07 1996-06-07 Administration par voie orale de produits de recombinaison geniques

Publications (1)

Publication Number Publication Date
AU6097896A true AU6097896A (en) 1996-12-30

Family

ID=23889916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60978/96A Abandoned AU6097896A (en) 1995-06-07 1996-06-07 Oral delivery of gene constructs

Country Status (6)

Country Link
EP (1) EP0831771A2 (fr)
JP (1) JPH11507340A (fr)
KR (1) KR19990022184A (fr)
AU (1) AU6097896A (fr)
CA (1) CA2221323A1 (fr)
WO (1) WO1996040081A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976571A (en) * 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
WO1996040954A1 (fr) * 1995-06-07 1996-12-19 Yale University Administration orale de vecteurs d'adenovirus
US6225290B1 (en) 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
ATE321882T1 (de) 1997-07-01 2006-04-15 Isis Pharmaceuticals Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
JP2002508530A (ja) * 1997-12-12 2002-03-19 シュノプティク アクティーゼルスカブ 物質の定時解放のための容器
CA2355237A1 (fr) * 1998-12-14 2000-06-22 Jorgen Bruun-Jensen Systeme de nettoyage de verres de contact
WO2002089855A1 (fr) * 2001-04-27 2002-11-14 Auckland Uniservices Limited Transduction perorale d'hepatocytes dans le traitement d'une maladie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233013T2 (de) * 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993019660A1 (fr) * 1992-04-03 1993-10-14 Baylor College Of Medicine Therapie genique utilisant l'intestin

Also Published As

Publication number Publication date
CA2221323A1 (fr) 1996-12-19
WO1996040081A3 (fr) 1997-02-20
EP0831771A2 (fr) 1998-04-01
WO1996040081A2 (fr) 1996-12-19
JPH11507340A (ja) 1999-06-29
KR19990022184A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
AUPO066096A0 (en) Oral delivery of peptides
AU5676596A (en) Oral insulin delivery
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU6625296A (en) Dna constructs
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
AU2543795A (en) Methods of in vivo gene delivery
AU2095599A (en) Human genes and gene expression products i
AU4053699A (en) Novel human genes and gene expression products
AU9692198A (en) Gene delivery compositions and methods
AU7675296A (en) Gum-massaging oral brush
AU5153296A (en) Vectors for gene delivery
AU7489896A (en) Feed enzyme preparations
AU4187499A (en) Human genes and gene expression products v
AU5968996A (en) Oral acyclovir delivery
AU6614696A (en) Inhibition of gene expression
AUPN741696A0 (en) Delivery of nucleic acids ii
AU6614596A (en) Inhibition of gene expression
AU5588096A (en) Oral formulations of S(+)-etodolac
AU1827799A (en) Oral delivery formulation
AU5978796A (en) Oral care ultramulsion based products
AU5312396A (en) Non-invasive imaging of gene transfer
AU4954496A (en) Gene transfer preparation
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU5401796A (en) Solid delivery form for oral use
AU6097896A (en) Oral delivery of gene constructs